Previous close | 0.0004 |
Open | 0.0004 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0004 - 0.0004 |
52-week range | 0.0001 - 0.0007 |
Volume | |
Avg. volume | 15,726,535 |
Market cap | 2.172M |
Beta (5Y monthly) | 57.91 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings date | 16 Jul 2024 - 22 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Reports 2024 First Quarter Revenues of $3.34 Million from Artizen CorporationSEATTLE, WASHINGTON, April 23, 2024 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced its 2024 first quarter financial results. Key Highlights Gross Profit for the quarter ending February 29, 2024 totaled $831,079 on $3,347,086 in revenues, compared to gross profits of $716,213 during the same period i
Reports 2023 Revenues of $15.8 Million from Artizen CorporationSEATTLE, WA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its fiscal years ended November 30, 2023. Key Highlights Gross Profit for the year ending November 30, 2023 totaled $4,890,763 on $15.8 million in revenues, compared to gross profits of $
SEATTLE, WA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, is pleased to announce the restructuring of its cannabis operations to convert about $15,000,000 in debt into 15% of a newly formed subsidiary. The restructuring is a prelude to the Company’s previously announced plan to spin that new subsidiary out into a standalone public entity on the OTCQB market. The Company has